source
- Geneticist Mary-Claire King awaits Nobel call after pioneering BRCA discoverySTAT spoke with geneticist Mary-Claire King, whose discovery of the BRCA1 and BRCA2 cancer mutations three decades ago has become a landmark in oncology. King recalled being invited to give a semi…
- Key criteria for selecting a biologics CDMO: reliability, cost, technology and partnership fitChoosing the right contract development and manufacturing organization is a strategic move for biotech and biopharma firms, as it can speed development and lower regulatory risk. The top priority…